Shanghai Model Organisms Center, Inc.

Equities

688265

CNE1000055L1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E. 18:00:00 2024-07-01 EDT 5-day change 1st Jan Change
21.12 CNY -4.95% Intraday chart for Shanghai Model Organisms Center, Inc. +1.64% -45.07%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Shanghai Model Organisms Center CFO Steps Down MT
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024. CI
Shanghai Model Organisms Center, Inc.'s Equity Buyback announced on February 24, 2024, has expired with 788,912 shares, representing 1.02% for CNY 21.45 million. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023. CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Shanghai Model Organisms Center, Inc. authorizes a Buyback Plan. CI
Shanghai Model Organisms Center, Inc.'s Equity Buyback announced on September 28, 2023 has closed with 451,318 shares, representing 0.58% for CNY 16.48 million. CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023. CI
Certain A Shares of Shanghai Model Organisms Center, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2023. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023. CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Model Organisms Center, Inc. authorizes a Buyback Plan. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Model Organisms Center, Inc.(SHSE:688265) added to Shanghai Stock Exchange A Share Index CI
Shanghai Model Organisms Center, Inc.(SHSE:688265) added to Shanghai Stock Exchange Composite Index CI
Certain A Shares of Shanghai Model Organisms Center, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2022. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shanghai Model Organisms Center, Inc. agreed to acquire Shanghai Zhongyingjian Health Technology Co., Ltd. from Shanghai Qihongxing Logistics Co., Ltd., Shanghai Haihua Environmental Engineering Co., Ltd. and Shanghai Weili Disinfectant Co., Ltd. for approximately CNY 400 million. CI
Chart Shanghai Model Organisms Center, Inc.
More charts
Shanghai Model Organisms Center Inc is a China-based company mainly engaged in gene modified animal models and related technical services. The Company's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.
More about the company

Annual profits - Rate of surprise